Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2012
03/14/2012EP2427448A1 Gpr 119 modulators
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427436A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
03/14/2012EP2427434A1 Process for preparing bromo-substituted quinolines
03/14/2012EP2200982B1 Piperidine derivatives as nk3 receptor antagonists
03/14/2012EP2036896B1 Cyclic amine compound
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1474420B1 Quinazoline compounds
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN1871003B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/14/2012CN102378761A Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
03/14/2012CN102378758A Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
03/14/2012CN102372696A Phenylcarbazole compounds and application thereof
03/14/2012CN102372695A Compound containing aryl pyridine rings, and application thereof
03/14/2012CN102372694A Aryl pyridine ring-contained carbazole compounds and application thereof
03/14/2012CN102372693A Carbazole compound and application thereof
03/14/2012CN102372692A Dihydropyridine derivative
03/14/2012CN102372691A Preparation process for (R)-3-benzene dicarboximide piperidine tartrate
03/14/2012CN102372690A Intermediate for synthesizing imatinib and application of intermediate in imatinib synthesis
03/14/2012CN102372659A Indolebenzamide derivatives and medicinal applications thereof
03/14/2012CN101528687B Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/14/2012CN101384559B Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/14/2012CN101318953B Insecticidal activity compound
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8134009 Process for the oxidation of secondary amines into the corresponding nitroxides
03/13/2012US8134008 Preparation of amorphous hydrous esomeprazole magnesium
03/13/2012US8134007 Pyridine derivatives
03/13/2012US8134000 Imidazolyl pyrimidine inhibitor compounds
03/13/2012US8133907 Type II diabetes, obesity, hyperglycemia and a lipid disorder selected from dyslipidemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, low HDL and high LDL; additionally comprising metformin
03/13/2012US8133905 Biphenyl compounds useful as muscarinic receptor antagonists
03/13/2012US8133901 3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
03/13/2012US8133896 Pyrimidine derivatives which are antagonist of the vitronectin receptor
03/13/2012US8133894 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
03/13/2012CA2656810C Biaryl benzoimidazole derivatives and pharmaceutical composition comprising the same
03/13/2012CA2586056C Aryloxy-substituted benzimidazole derivative
03/13/2012CA2565812C 4-phenylamino-quinazolin-6-yl-amides
03/13/2012CA2480468C Fredericamycin derivatives
03/08/2012WO2012031220A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
03/08/2012WO2012031199A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012WO2012031090A2 Small molecule inhibitors of ebola and lassa fever viruses and methods of use
03/08/2012WO2012031004A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012WO2012030948A1 Quinazoline compounds and methods of use thereof
03/08/2012WO2012030944A2 Quinoline and isoquinoline compounds and methods of use thereof
03/08/2012WO2012030922A1 Fungicidal pyrazoles
03/08/2012WO2012030918A1 Adenosine a3 receptor modulating compounds and methods of use thereof
03/08/2012WO2012030258A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
03/08/2012WO2012030145A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
03/08/2012WO2012029836A1 Method for producing 1-triazole-2-butanol derivative
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012029326A1 3-pyrazolyl-2-pyridone derivative
03/08/2012WO2012029253A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same
03/08/2012WO2012028629A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
03/08/2012WO2012028579A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
03/08/2012WO2012028578A1 Substituted fused pyrimidinones and dihydropyrimidinones
03/08/2012WO2012028332A1 Pharmaceutically active compounds as axl inhibitors
03/08/2012WO2012028106A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
03/08/2012WO2012007877A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012003912A8 Bipyridyl derivatives useful for the treatment of kinase - induced diseases
03/08/2012WO2011151618A3 Compounds for the treatment of clostridium difficile associated disease (cdad)
03/08/2012WO2011134911A3 Fungicide hydroximoyl-tetrazole derivatives
03/08/2012WO2011133875A3 Metalloenzyme inhibitor compounds
03/08/2012WO2010124121A8 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
03/08/2012US20120059037 Substituted pyridine derivatives and their medical use
03/08/2012US20120059032 1,2,3,4-tetrahydroisoquinoline derivatives effective as antiglioma agents, methods of making, and their use
03/08/2012US20120059017 CGRP Receptor Antagonist
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059003 Inhibitors of inv(16) leukemia
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059000 Chemical compounds, compositions and methods for kinase modulation
03/08/2012US20120058996 Carbazole carboxamide compounds useful as kinase inhibitors
03/08/2012US20120058994 Novel compounds
03/08/2012US20120058987 Therapeutic uses of quinazolinedione derivatives
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058892 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and their use as herbicides
03/08/2012US20120058482 Functionalized cyanine dyes (peg)
03/08/2012CA2810049A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2809836A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012CA2809487A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2809178A1 Tyrosine kinase inhibitors
03/08/2012CA2808912A1 Modified-release dosage forms of 5-ht2c agonists useful for weight management
03/08/2012CA2808230A1 Process for producing 1-triazole-2-butanol derivatives
03/08/2012CA2808144A1 Pest control agent
03/08/2012CA2807620A1 Pharmaceutically active compounds as axl inhibitors
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426122A1 Methylene urea derivative as RAF kinasse inhibitors
03/07/2012EP2426121A1 Quaternary ammonium salt compound
03/07/2012EP2426120A1 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them
03/07/2012EP2426119A1 Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
03/07/2012EP2426118A1 Methods of making the polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2426109A1 Novel kinase inhibitors
03/07/2012EP2426107A1 Transition metal conjugated radiopharmaceuticals useful as therapeutic and/or diagnostic agents
03/07/2012EP2425840A1 Triazine derivatives and their therapeutical applications
03/07/2012EP2425836A1 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 1080